neomycin - CISMeF

Preferred Label : neomycin;

MeSH definition : Antibiotic complex produced by Streptomyces fradiae. It is composed of neomycins A, B, and C. It acts by inhibiting translation during protein synthesis.; Aminoglycoside antibiotic complex produced by Streptomyces fradiae. It is composed of neomycins A, B, and C, and acts by inhibiting translation during protein synthesis.;

CISMeF synonym : palmitate, neomycin; sulfate, fradiomycin; sulfate, neomycin;

MeSH hyponym : Neomycin Sulfate; Neomycin Palmitate; Fradiomycin Sulfate;

MeSH CAS label : neomycin;

MeSH Related Number : neomycin sulfate; neomycin palmitate; 140-12-5 (palmitate); 1405-10-3 (sulfate (salt)); 057Y626693; 1404-04-2 (Neomycin); 1405-10-3 (Sulfate); 3I9J454G9F;

Registry Number MeSH : 1404-04-2;

Related CAS MeSH : 1405-10-3 (Neomycin sulfate); 140-12-5 (Neomycin palmitate);

Wikipedia link : https://en.wikipedia.org/wiki/Neomycin;

Codes EINECS : 215-766-3;

Is substance : O;

medicament (CISMeF) : O;

UNII : I16QD7X297;

Details

Origin ID

D009355;

UMLS CUI

C0027603;

ATC code(s)
- neomycin [ATC Code]
- neomycin [ATC Code]
ATC code(s)
- neomycin [ATC Code]
- neomycin [ATC Code]
- neomycin [ATC Code]
- neomycin [ATC Code]
- neomycin [ATC Code]
- neomycin [ATC Code]
- neomycin [ATC Code]
- neomycin [ATC Code]
- neomycin [ATC Code]
- neomycin, combinations [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Neamine [NCIt concept]
- Neomycin (derivatives) [ICHI extension code]
- Neomycin Palmitate [NCIt concept]
- Neomycin Sulfate [NCIt concept]
- Neomycin palmitate (substance) [SNOMED CT concept]
- Neomycin sulfate (substance) [SNOMED CT concept]
- framycetin [Substance BNPC]
- neomycin b [SNOMED Notion]
- neomycin c [SNOMED Notion]
- neomycin palmitate [SNOMED Notion]
- neomycin sulfate [SNOMED Notion]
- paromomycin [Substance BNPC]
CISMeF manual mappings
- neomycin [Substance BNPC]
Pharmacological action(s)
- anti-bacterial agents [MeSH Descriptor]
- protein synthesis inhibitors [MeSH Descriptor]
Record concept(s)
- Neomycin Palmitate [MeSH concept]
- Neomycin Sulfate [MeSH concept]
- neomycin [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1-N-(s)-4-amino-2-hydroxybutyryl-3'4'-deoxyneamine [MeSH Supplementary Concept]
- 3'-O-methylneamine [MeSH Supplementary Concept]
- 4'-O-methylneamine [MeSH Supplementary Concept]
- 4'-deoxyneomycin [MeSH Supplementary Concept]
- 4'-octadecylneamine [MeSH Supplementary Concept]
- Cysto-Myacyne [MeSH Supplementary Concept]
- Gramicidin, Neomycin Sulfate, Nystatin, Triamcinolone Acetonide Drug Combination [MeSH Supplementary Concept]
- HDR hydrogel [MeSH Supplementary Concept]
- NEOF004 [MeSH Supplementary Concept]
- Nebacetin [MeSH Supplementary Concept]
- NeoR6 compound [MeSH Supplementary Concept]
- Panotile [MeSH Supplementary Concept]
- acetarsol, dimethicone, neomycin, nystatin, polymyxin drug combination [MeSH Supplementary Concept]
- bacitracin zinc, neomycin sulfate, polymyxin B, drug combination [MeSH Supplementary Concept]
- bacitracin, cysteine, glycine, neomycin, threonine drug combination [MeSH Supplementary Concept]
- betamethasone 17-valerate, neomycin drug combination [MeSH Supplementary Concept]
- betamethasone, neomycin drug combination [MeSH Supplementary Concept]
- chloramphenicol, dexamethasone, neomycin drug combination [MeSH Supplementary Concept]
- chlorobutanol, methylprednisolone, neomycin drug combination [MeSH Supplementary Concept]
- dexamethasone, neomycin, polymyxin B drug combination [MeSH Supplementary Concept]
- diaropect [MeSH Supplementary Concept]
- dicortineff [MeSH Supplementary Concept]
- dimethindene, neomycin, phenylephrine drug combination [MeSH Supplementary Concept]
- dimethylaminopropylneomycin [MeSH Supplementary Concept]
- dodeca-N-methylneomycin hexamethochloride [MeSH Supplementary Concept]
- fluocinolone-neomycin combination [MeSH Supplementary Concept]
- fokalmin [MeSH Supplementary Concept]
- fradicin [MeSH Supplementary Concept]
- hydrocortisone, neomycin, polymyxin B drug combination [MeSH Supplementary Concept]
- maxitrol [MeSH Supplementary Concept]
- naseptin [MeSH Supplementary Concept]
- neomedrol-veriderm [MeSH Supplementary Concept]
- neomycin B-glucoside [MeSH Supplementary Concept]
- neomycin sulfate, pyridine carboxylate of dexamethasone, tyzanol drug combination [MeSH Supplementary Concept]
- neomycin, prednisolone, surfen, trypsin-chymotrypsin drug combination [MeSH Supplementary Concept]
- neopredin [MeSH Supplementary Concept]
- neoterramycin [MeSH Supplementary Concept]
- neotil [MeSH Supplementary Concept]
- neotizol [MeSH Supplementary Concept]
- oterna [MeSH Supplementary Concept]
- otomize [MeSH Supplementary Concept]
- panalog [MeSH Supplementary Concept]
- pimafucort [MeSH Supplementary Concept]
- polymyxin B sulfate, neomycin sulfate, sulfonamide, and hydrocortisone drug combination [MeSH Supplementary Concept]
- polyspectran OS [MeSH Supplementary Concept]
- predni aquos opthiole [MeSH Supplementary Concept]
- septomixine [MeSH Supplementary Concept]
- tresaderm [MeSH Supplementary Concept]
- trofodermin [MeSH Supplementary Concept]
- tuplix [MeSH Supplementary Concept]
- uniroid [MeSH Supplementary Concept]
Semantic type(s)
- Antibiotic [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Neomycin [NCIt concept]
- Neomycin [LOINC component]
- Neomycin (substance) [SNOMED CT concept]
- Product containing neomycin (medicinal product) [SNOMED CT concept]
- neomycin [ATC Code]
- neomycin [ATC Code]
- neomycin [ATC Code]
- neomycin [ATC Code]
- neomycin [ATC Code]
- neomycin [ATC Code]
- neomycin [ATC Code]
- neomycin [ATC Code]
- neomycin [ATC Code]
- neomycin [Substance BNPC]
- neomycin [SNOMED Notion]
Validated automatic mappings to BTNT
- NEOMYCIN PALMITATE [SMS substance]
- NEOMYCIN SULFATE [SMS substance]
- Neomycin Sulfate [NCIt concept]
- Neomycin palmitate (substance) [SNOMED CT concept]
- Neomycin sulfate (substance) [SNOMED CT concept]
- neomycin [ATC Code]
- neomycin [ATC Code]
- neomycin [ATC Code]
- neomycin [ATC Code]
- neomycin [ATC Code]
- neomycin [ATC Code]
- neomycin [ATC Code]
- neomycin [ATC Code]
- neomycin [ATC Code]
- neomycin palmitate [SNOMED Notion]
- neomycin sulfate [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients